Table 2 |
|||||||||
| Patient characteristics (Mag + BB group/BB group) of randomized controlled studies | |||||||||
| Study | Number of patients | Mean age (years) | Men (%) | Mean LVEF (%) | Hypertens-ion (%) | Diabetes (%) | Preop BB (%) | Preop digoxin(%) | Preop CCB (%) |
| Bert et al. [19] | 69/71 | 62.3/63.8 | 82.6/76.1 | 48/49 | NA | NA | 75.4/76.1 | 21.2/21.2 | 17.2/18.5 |
| Cook et al. [22] | 347/347 | 64/64 | 85.6/83.6 | NA | 66.9/68 | 35.7/30.8 | 88.2/89 | 1.7/0.9 | 27.7/24.5 |
| Forlani et al. [20] | 52/51 | 62/64 | 91/82 | 55.3/54.7 | 63/72 | 25/38 | 36/45 | 7/3 | 14/16 |
| Geertman et al. [21] | 74/73 | 63.8/61.7 | 78.4/79.5 | NA | 32/30 | 13.5/8.2 | 90.5/86.3 | NA | NA |
| Solomon et al. [23] | 85/82 | 62/61 | 80/73 | 53/54 | NA | NA | 72/78 | 3.5/7.3 | 39/37 |
Mag: magnesium; BB: beta-blocker; CCB: calcium channel blocker; NA: data not available; LVEF: left ventricular ejection fraction; Preop: preoperative.
Wu et al. BMC Cardiovascular Disorders 2013 13:5 doi:10.1186/1471-2261-13-5
